Sabra Health Care REIT (NASDAQ:SBRA) Posts Earnings Results, Misses Expectations By $0.04 EPS

Sabra Health Care REIT (NASDAQ:SBRA) posted its quarterly earnings data on Wednesday, May 9th. The real estate investment trust reported $0.34 earnings per share for the quarter, missing the consensus estimate of $0.38 by ($0.04), Fidelity Earnings reports. Sabra Health Care REIT had a return on equity of 7.19% and a net margin of 39.69%. The firm had revenue of $166.09 million for the quarter, compared to analysts’ expectations of $161.90 million.

NASDAQ SBRA traded down $0.47 during trading hours on Friday, hitting $19.11. The company’s stock had a trading volume of 38,140 shares, compared to its average volume of 1,913,034. Sabra Health Care REIT has a twelve month low of $19.78 and a twelve month high of $20.16. The firm has a market capitalization of $3.54 billion, a P/E ratio of 7.89, a P/E/G ratio of 2.59 and a beta of 0.64. The company has a debt-to-equity ratio of 0.98, a current ratio of 1.55 and a quick ratio of 1.55.

The business also recently declared a quarterly dividend, which will be paid on Thursday, May 31st. Stockholders of record on Monday, May 21st will be paid a dividend of $0.45 per share. The ex-dividend date of this dividend is Friday, May 18th. This represents a $1.80 annualized dividend and a dividend yield of 9.42%. Sabra Health Care REIT’s dividend payout ratio (DPR) is currently 74.07%.



A number of equities research analysts recently issued reports on the stock. ValuEngine upgraded shares of Sabra Health Care REIT from a “strong sell” rating to a “sell” rating in a report on Friday, May 11th. Cantor Fitzgerald reissued a “buy” rating and set a $25.00 target price on shares of Sabra Health Care REIT in a research report on Wednesday, May 9th. BidaskClub raised shares of Sabra Health Care REIT from a “sell” rating to a “hold” rating in a research report on Wednesday, May 2nd. JMP Securities boosted their target price on shares of Sabra Health Care REIT from $19.00 to $21.00 and gave the stock an “outperform” rating in a research report on Monday. Finally, Wells Fargo cut their price objective on shares of Sabra Health Care REIT from $24.00 to $19.00 and set a “market perform” rating for the company in a research report on Tuesday, March 20th. They noted that the move was a valuation call. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and four have given a buy rating to the company. Sabra Health Care REIT has an average rating of “Hold” and an average target price of $22.50.

Sabra Health Care REIT Company Profile

As of December 31, 2017, Sabra's investment portfolio included 507 real estate properties held for investment (consisting of (i) 384 Skilled Nursing/Transitional Care facilities, (ii) 88 Senior Housing – Leased communities, (iii) 13 Senior Housing – Managed communities and (iv) 22 Acute Care Hospitals), one investment in a direct financing lease, 22 investments in loans receivable (consisting of (i) two mortgage loans, (ii) two construction loans, (iii) two mezzanine loans, (iv) one pre-development loan and (v) 15 other loans), 12 preferred equity investments and one investment in a specialty valuation firm.

Earnings History for Sabra Health Care REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply